Truncating SRCAP variants outside the Floating-Harbor syndrome locus cause a distinct neurodevelopmental disorder with a specific DNA methylation signature

DNA methylation signature nonsense-mediated decay Heart Septal Defects, Ventricular Male 0301 basic medicine speech delay PROTEIN PHENOTYPE Medical and Health Sciences Epigenesis, Genetic Cohort Studies Craniofacial Abnormalities 2.1 Biological and endogenous factors Paediatrics - Radboud University Medical Center Aetiology Growth Disorders non-FLHS SRCAP-related NDD Genetics & Heredity Adenosine Triphosphatases neurodevelopmental disorders SOTOS-LIKE Biological Sciences SRCAP AT-HOOK 3. Good health Mental Health Phenotype intellectual disability Female Abnormalities Radboudumc 6: Metabolic Disorders RIMLS: Radboud Institute for Molecular Life Sciences Multiple EXON 34 Intellectual and Developmental Disabilities (IDD) 610 genotype-phenotype correlation DIAGNOSIS Article 03 medical and health sciences Genetic Clinical Research Genetics Humans Abnormalities, Multiple Genetic Predisposition to Disease Floating-Harbor syndrome SPECTRUM DNA methylation signature; Floating-Harbor syndrome; SRCAP; epigenomics; genotype-phenotype correlation; intellectual disability; neurodevelopmental disorders; non-FLHS SRCAP-related NDD; nonsense-mediated decay; speech delay Radboudumc 7: Neurodevelopmental disorders DCMN: Donders Center for Medical Neuroscience MUTATIONS Heart Septal Defects Ventricular Infant, Newborn Infant DNA Methylation Newborn GENE Brain Disorders Neurodevelopmental Disorders Case-Control Studies epigenomics Mutation Human Genetics - Radboud University Medical Center EPISIGNATURES Epigenesis
DOI: 10.1016/j.ajhg.2021.04.008 Publication Date: 2021-04-27T16:38:01Z
ABSTRACT
Truncating variants in exons 33 and 34 of the SNF2-related CREBBP activator protein (SRCAP) gene cause neurodevelopmental disorder (NDD) Floating-Harbor syndrome (FLHS), characterized by short stature, speech delay, facial dysmorphism. Here, we present a cohort individuals with clinical features distinct from FLHS truncating (mostly de novo) SRCAP either proximal (n = 28) or distal 5) to locus. Detailed characterization identified shared characteristics: developmental delay without intellectual disability, behavioral psychiatric problems, non-specific features, musculoskeletal issues, hypotonia. Because is known be associated unique set DNA methylation (DNAm) changes blood, DNAm signature, investigated whether there was signature our affected individuals. A machine-learning model, based on negatively classified all tested subjects. Comparing typically developing controls, signature. Based data, refer condition as "non-FLHS SRCAP-related NDD." All five using model while two positively model. This suggests divergent pathogenicity these variants, though clinically group presented NDD, similar group. In summary, for SRCAP, clear relationship between variant location, profile, phenotype. These results highlight power combined epigenetic, molecular, studies identify characterize genotype-epigenotype-phenotype correlations.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (62)
CITATIONS (50)